Tiger Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Tiger Management’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-137,728	Closed	-$1.24M	–	38
2022 Q1	$1.24M	Hold	137,728	–	–	0.2%	28
2021 Q4	$1.91M	Hold	137,728	–	–	0.37%	23
2021 Q3	$1.47M	Hold	137,728	–	–	0.27%	30
2021 Q2	$1.24M	Hold	137,728	–	–	0.22%	31
2021 Q1	$1.46M	Hold	137,728	–	–	0.29%	30
2020 Q4	$1.74M	Hold	137,728	–	–	0.39%	26
2020 Q3	$1.21M	Hold	137,728	–	–	0.34%	31
2020 Q2	$1.34M	Hold	137,728	–	–	0.37%	27
2020 Q1	$397K	Hold	137,728	–	–	0.13%	40
2019 Q4	$529K	Hold	137,728	–	–	0.15%	25
2019 Q3	$545K	Hold	137,728	–	–	0.21%	21
2019 Q2	$580K	Hold	137,728	–	–	0.24%	20
2019 Q1	$945K	Sell	137,728 -25,000	-15%	-$156K	0.26%	20
2018 Q4	$599K	Hold	162,728	–	–	0.15%	26
2018 Q3	$1.03M	Hold	162,728	–	–	0.1%	68
2018 Q2	$1.23M	Hold	162,728	–	–	0.25%	53
2018 Q1	$1.3M	Hold	162,728	–	–	0.17%	63
2017 Q4	$1.82M	Hold	162,728	–	–	0.28%	37
2017 Q3	$1.89M	Sell	162,728 -1	-0%	-$9	0.34%	32
2017 Q2	$1.57M	Hold	162,729	–	–	0.31%	32
2017 Q1	$1.9M	Hold	162,729	–	–	0.36%	39
2016 Q4	$1.46M	Hold	162,729	–	–	0.26%	31
2016 Q3	$5.29M	Hold	162,729	–	–	1.25%	17
2016 Q2	$2.99M	Hold	162,729	–	–	0.97%	19
2016 Q1	$2.71M	Hold	162,729	–	–	0.68%	29
2015 Q4	$5.04M	Hold	162,729	–	–	0.65%	26
2015 Q3	$8.44M	Buy	+162,729	New	+$10.7M	1.13%	24

Other funds holding ALPN

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tiger Management's ALPN Position: Q2 2022 in Review

Tiger Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2022, closing a stake of 137,728 shares — an estimated $1.24M sold.

Tiger Management first reported a position in ALPN in Q3 2015 and held it in 27 quarters. The position peaked at $8.44M in Q3 2015. 58 funds tracked by Wall St. Rank hold ALPN as of Q2 2022.

Tiger Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2022 after selling out during the quarter.
Tiger Management sold 137,728 Alpine Immune Sciences Inc shares in Q2 2022, an estimated $1.24M.
Tiger Management first reported a position in Alpine Immune Sciences Inc in Q3 2015 and held it in 27 quarters.
Tiger Management's Alpine Immune Sciences Inc position peaked at $8.44M in Q3 2015.
58 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2022.

Based on Tiger Management's 13F filing for Q2 2022, filed 15 Aug 2022.